SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950162-07-000035
Filing Date
2007-01-12
Accepted
2007-01-12 16:02:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 DOR BIOPHARMA/SIGMA TAU AMERICA S.A. - SCHEDULE 13G - 01/03/07 sigmatauamerica13g_010307.htm SC 13G 334752
  Complete submission text file 0000950162-07-000035.txt   336869
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 07528838
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19-21, BOULEVARD DU PRINCE HENRI L-1724 LUXEMBOURG N4 00000
Business Address 19-21, BOULEVARD DU PRINCE HENRI L-1724 LUXEMBOURG N4 00000 1-800-447-0169
Sigma-Tau America S.A. (Filed by) CIK: 0001385930 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G